• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 型利钠肽是 CKD 儿科患者心脏应变的可靠标志物。

B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients.

机构信息

Pediatric Nephrology, Shaare Zedek Medical Center, The Hadassah-Hebrew University School of Medicine, Jerusalem, Israel.

出版信息

Pediatr Nephrol. 2012 Apr;27(4):617-25. doi: 10.1007/s00467-011-2025-4. Epub 2011 Oct 27.

DOI:10.1007/s00467-011-2025-4
PMID:22038201
Abstract

Myocardial damage and strain are common in children with chronic renal failure. The most prevalent pathologies, as defined by echocardiography, are left ventricular hypertrophy (LVH), diastolic and systolic dysfunction, and altered LV geometry. Troponin I and T, as well as B-type natriuretic peptide (BNP) and its cleavage fragment NT-proBNP, are known to be good markers of myocardial damage and stress, respectively, in the general adult population and among those with chronic kidney disease (CKD). In this study we measured the levels of troponins I and T, BNP, and NT-proBNP in a group of children and young adults with CKD stages 3-5 and determined their respective correlations with echocardiographic and laboratory abnormalities. BNP and NT-proBNP levels and their log values correlated well with the following parameters: diastolic blood pressure, estimated glomerular filtration rate, time-averaged hemoglobin levels, and LV mass. Both BNP and NT-proBNP levels, but not those of either troponin, were found to be reliable surrogate markers of strained hearts, defined as having LVH or diastolic or systolic dysfunction, in the pediatric CKD stages 3-4 group. The log NT-proBNP value was also found to be a good marker of cardiac strain in the CKD stage 5 group of patients. Serum BNP and NT-proBNP threshold concentrations of 43 and 529 pg/ml, respectively, were found to have the best sensitivity and specificity in predicting strained hearts. Based on these findings, we conclude that both BNP and NT-proBNP levels, but not those of troponins I and T, can serve as inexpensive, simple, and reliable markers of stressed hearts in the pediatric CKD patient population.

摘要

心肌损伤和应变在慢性肾衰竭儿童中很常见。超声心动图定义的最常见病变是左心室肥厚(LVH)、舒张和收缩功能障碍以及左心室几何形状改变。肌钙蛋白 I 和 T 以及 B 型利钠肽(BNP)及其裂解片段 NT-proBNP 在一般成年人群和慢性肾脏病(CKD)患者中分别被认为是心肌损伤和应激的良好标志物。在这项研究中,我们测量了一组 CKD 3-5 期儿童和年轻患者的肌钙蛋白 I 和 T、BNP 和 NT-proBNP 水平,并确定了它们与超声心动图和实验室异常的各自相关性。BNP 和 NT-proBNP 水平及其对数与以下参数密切相关:舒张压、估计肾小球滤过率、平均血红蛋白水平和左心室质量。在儿科 CKD 3-4 期患者中,BNP 和 NT-proBNP 水平(而非肌钙蛋白水平)均被发现是 LVH 或舒张或收缩功能障碍的紧张心脏的可靠替代标志物。NT-proBNP 对数值也被发现是 CKD 5 期患者心脏紧张的良好标志物。血清 BNP 和 NT-proBNP 分别为 43 和 529 pg/ml 的截断浓度被发现对预测紧张心脏具有最佳的敏感性和特异性。基于这些发现,我们得出结论,BNP 和 NT-proBNP 水平(而非肌钙蛋白 I 和 T 水平)可作为儿科 CKD 患者群体中紧张心脏的廉价、简单和可靠标志物。

相似文献

1
B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients.B 型利钠肽是 CKD 儿科患者心脏应变的可靠标志物。
Pediatr Nephrol. 2012 Apr;27(4):617-25. doi: 10.1007/s00467-011-2025-4. Epub 2011 Oct 27.
2
Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.B 型利钠肽在检测β-地中海贫血症患者隐匿性左心室舒张功能障碍中的预测价值。
Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.
3
B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.B 型利钠肽与氨基末端 pro-B 型利钠肽:在肾功能受损患者中选择最佳心力衰竭标志物。
BMC Nephrol. 2013 May 31;14:117. doi: 10.1186/1471-2369-14-117.
4
Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).N 末端脑利钠肽前体与慢性肾脏病患者左心室结构和功能的相关性(来自慢性肾功能不全队列研究 [CRIC])。
Am J Cardiol. 2013 Feb 1;111(3):432-8. doi: 10.1016/j.amjcard.2012.10.019. Epub 2012 Nov 22.
5
B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.慢性肾脏病患者的B型利钠肽(BNP)和氨基末端proBNP:与肾功能及左心室肥厚的关系
Am J Kidney Dis. 2005 Oct;46(4):610-20. doi: 10.1053/j.ajkd.2005.06.017.
6
Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.B 型利钠肽及其氨基末端 proBNP 片段对肾功能分层的心血管事件的预后价值。
J Cardiol. 2013 Jun;61(6):410-6. doi: 10.1016/j.jjcc.2013.01.015. Epub 2013 Apr 22.
7
Cardiac biomarkers in pediatric CKD-a prospective follow-up study.儿科 CKD 的心脏生物标志物:一项前瞻性随访研究。
Pediatr Nephrol. 2022 Dec;37(12):3165-3175. doi: 10.1007/s00467-022-05481-w. Epub 2022 Mar 16.
8
Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.高血压合并代谢综合征患者的超声心动图评估及N末端脑钠肽前体
Adv Clin Exp Med. 2017 Mar-Apr;26(2):295-301. doi: 10.17219/acem/33554.
9
[B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].[B型利钠肽作为慢性肾脏病患儿心脏功能障碍的标志物]
Pol Merkur Lekarski. 2018 Apr 23;44(262):171-176.
10
Natriuretic peptides in chronic kidney disease.慢性肾脏病中的利钠肽
Clin J Am Soc Nephrol. 2008 Nov;3(6):1644-51. doi: 10.2215/CJN.00850208. Epub 2008 Jul 16.

引用本文的文献

1
Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions.B 型利钠肽和 N 端 B 型利钠肽原在儿科患者中的临床意义:预先存在的心脏疾病对其应用价值的影响。
Int J Mol Sci. 2024 Aug 12;25(16):8781. doi: 10.3390/ijms25168781.
2
Potential Role of Novel Cardiovascular Biomarkers in Pediatric Patients with Chronic Kidney Disease.新型心血管生物标志物在慢性肾脏病患儿中的潜在作用。
Mini Rev Med Chem. 2024;24(5):491-506. doi: 10.2174/1389557523666230523114331.
3
Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study.

本文引用的文献

1
A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure.对慢性肾衰竭儿童的心血管危险因素、心功能和血管疾病进行全面研究。
Nephrol Dial Transplant. 2010 Mar;25(3):785-93. doi: 10.1093/ndt/gfp570. Epub 2009 Nov 23.
2
Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors.儿童慢性肾脏病的当前进展:生长、心血管和神经认知危险因素
Semin Nephrol. 2009 Jul;29(4):425-34. doi: 10.1016/j.semnephrol.2009.03.017.
3
Age-specific reference intervals for indexed left ventricular mass in children.
慢性肾脏病患儿及肾移植受者的血浆脑钠肽水平:一项单中心研究
Children (Basel). 2022 Jun 19;9(6):916. doi: 10.3390/children9060916.
4
Cardiac biomarkers in pediatric CKD-a prospective follow-up study.儿科 CKD 的心脏生物标志物:一项前瞻性随访研究。
Pediatr Nephrol. 2022 Dec;37(12):3165-3175. doi: 10.1007/s00467-022-05481-w. Epub 2022 Mar 16.
5
NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease.N末端B型利钠肽原作为慢性肾脏病患儿心血管损伤的潜在标志物
J Clin Med. 2021 Sep 24;10(19):4344. doi: 10.3390/jcm10194344.
6
Multi-Organ Dysfunction in Cerebral Palsy.脑瘫中的多器官功能障碍
Front Pediatr. 2021 Aug 9;9:668544. doi: 10.3389/fped.2021.668544. eCollection 2021.
7
Cardiac Biomarkers in Pediatrics: An Undervalued Resource.儿科心脏生物标志物:被低估的资源。
Clin Chem. 2021 Jul 6;67(7):947-958. doi: 10.1093/clinchem/hvab063.
8
Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease.评估慢性肾脏病患儿心脏功能的纵向变化趋势。
Pediatr Nephrol. 2016 Sep;31(9):1485-97. doi: 10.1007/s00467-016-3371-z. Epub 2016 Apr 7.
9
Cardiorenal syndrome is present in human fetuses with severe, isolated urinary tract malformations.Cardiorenal 综合征存在于伴有严重孤立性尿路畸形的人类胎儿中。
PLoS One. 2013 May 22;8(5):e63664. doi: 10.1371/journal.pone.0063664. Print 2013.
10
Can dialysis modality influence cardiovascular outcome?透析方式会影响心血管结局吗?
Pediatr Nephrol. 2012 Nov;27(11):2001-2005. doi: 10.1007/s00467-012-2207-8. Epub 2012 Jun 3.
儿童左心室质量指数的年龄特异性参考区间
J Am Soc Echocardiogr. 2009 Jun;22(6):709-14. doi: 10.1016/j.echo.2009.03.003. Epub 2009 May 7.
4
New equations to estimate GFR in children with CKD.估算慢性肾脏病儿童肾小球滤过率的新方程。
J Am Soc Nephrol. 2009 Mar;20(3):629-37. doi: 10.1681/ASN.2008030287. Epub 2009 Jan 21.
5
Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.N末端脑钠肽前体在合并与未合并慢性肾脏病的心力衰竭患者中预后价值的比较
Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082. Epub 2008 May 24.
6
NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.婴幼儿和儿童的N末端B型利钠肽原:基于四项研究合并数据的参考值
Pediatr Cardiol. 2009 Jan;30(1):3-8. doi: 10.1007/s00246-008-9258-4. Epub 2008 Jul 4.
7
Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients.无症状血液透析患者中N末端前B型利钠肽原和心肌肌钙蛋白T与左心室质量、功能及死亡率的关系
Am J Kidney Dis. 2007 Dec;50(6):1009-19. doi: 10.1053/j.ajkd.2007.08.017.
8
Impact of hemoglobin on plasma pro-B-type natriuretic peptide concentrations in the general population.血红蛋白对普通人群血浆前B型利钠肽浓度的影响。
Clin Chem. 2007 Nov;53(11):1921-7. doi: 10.1373/clinchem.2007.089391. Epub 2007 Sep 14.
9
Risk factors for cardiovascular disease in children and young adults after renal transplantation.肾移植后儿童和青年人心血管疾病的危险因素。
Clin J Am Soc Nephrol. 2006 Nov;1(6):1284-92. doi: 10.2215/CJN.01480506. Epub 2006 Sep 20.
10
N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.N末端脑钠肽前体可预测终末期肾病血液透析患者的死亡率。
Kidney Int. 2007 Mar;71(6):548-54. doi: 10.1038/sj.ki.5002087. Epub 2007 Feb 14.